Related Experiment Video
Updated: Feb 21, 2026
A Method for Evaluating Insecticide Efficacy against Bed Bug, Cimex lectularius, Eggs and First Instars
Published on: March 15, 2017
Effect of Moxidectin on Bed Bug Feeding, Development, Fecundity, and Survivorship
Chen Zha1, Changlu Wang2, Johnathan Michael Sheele3
1Department of Entomology, Rutgers-The State University of New Jersey, New Brunswick, NJ 08901, USA. cz166@scarletmail.Rutgers.edu.
Abstract:
The common bed bug, Cimex lectularius L. (Hemiptera: Cimicidae), is a blood-feeding ectoparasite which experienced world-wide resurgence during recent decades. The control of bed bugs is often challenging, due to their cryptic nature and resistance to commonly used insecticides. In this study, we evaluated the effect of the antiparasitic drug moxidectin on bed bug survival, reproduction, and development. The LC50 (lethal concentration to kill half the members of a tested population) of moxidectin against bed bug male adults, female adults, and large nymphs were 52.7 (95% CI (confidence interval): 39.5-70.8), 29.3 (95% CI: 20.7-40.5), and 29.1 ng/mL (95% CI: 23.3-35.3), respectively. Moxidectin (≥ 25 ng/mL) reduced egg laying of bed bug females, but showed no significant effect on egg hatching. One time feeding on rabbit blood containing 20 and 40 ng/mL moxidectin showed no negative effects in bed bug feeding and blood meal ingestion, but significantly reduced digestion rates and nymph molting rates. Although moxidectin at concentrations of 20 and 40 ng/mL only caused moderate mortality in bed bugs, it significantly interrupted digestion, development, and oviposition of survived bed bugs for at least one week after feeding. Moxidectin is a promising supplement of the existing bed bug control materials if its use on humans can be approved in the future.
Insights
The antiparasitic drug moxidectin shows potential for bed bug control by reducing survival, reproduction, and development. Even at sub-lethal doses, moxidectin significantly disrupts digestion and molting in common bed bugs (Cimex lectularius).
Area of Science:
- Entomology
- Parasitology
- Pest Management
Background:
- The common bed bug (Cimex lectularius) has resurged globally, posing significant control challenges due to insecticide resistance and cryptic behavior.
- Existing control methods are often insufficient, necessitating the exploration of novel agents for effective bed bug management.
Purpose of the Study:
- To evaluate the efficacy of the antiparasitic drug moxidectin against the common bed bug, Cimex lectularius.
- To assess moxidectin's impact on bed bug survival, reproduction (oviposition and hatching), and developmental processes.
Main Methods:
- Determined the lethal concentration (LC50) of moxidectin for male adults, female adults, and large nymphs of Cimex lectularius.
- Assessed the effects of moxidectin exposure on egg laying, egg hatching, feeding behavior, blood meal digestion, and nymphal molting rates.
- Administered moxidectin via rabbit blood meals at concentrations of 20 and 40 ng/mL.
Main Results:
- Moxidectin exhibited lethal concentrations (LC50) ranging from 29.1 to 52.7 ng/mL for different life stages.
- Concentrations of 20 and 40 ng/mL moxidectin significantly reduced digestion rates and nymph molting, and interrupted oviposition.
- While not causing high mortality at these concentrations, moxidectin significantly impacted digestion and development for at least a week post-exposure.
Conclusions:
- Moxidectin demonstrates significant potential as a supplementary agent for managing bed bug populations, impacting key life cycle processes.
- Further research into the potential human application of moxidectin is warranted for integrated pest management strategies against Cimex lectularius.
